Voting rights: Q-Cells AG: Publication pursuant to §26 sect.1 WpHG with the aim of pan-European distribution

13 mei 2008Q-Cells AG / Q-Cells AG: Release of a voting rights announcement according to section 26, para. 1 WpHG (Securities Trading Act) with the aim of a European wide distribution Publication pursuant to §26 sect.1 WpHG processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Release of a voting rights announcement pursuant to sections 21, 22 WpHG (Federal Securities Trading Act): Nordhues & Cie. LLP, with its registered office in Frankfurt/Main, Germany, notified us in the name and on behalf of Impala Asset Advisors, LLC, New Canaan, USA, on 07 May 2008, of the following: On 22 April 2008, the voting rights in Q-Cells AG exercised by Impala Asset Advisors, LLC., have fallen below the threshold of 3 % of the voting rights in Q-Cells AG and as of that day reached 2.68 % of the voting rights in Q-Cells AG, arising from 2,166,406 voting rights. The voting rights were to be allocated to a) Impala Fund LP (a Delaware limited partnership) for 1.03 per cent of the voting rights (831,367 shares); and b) Impala Alternative Energy Fund LP for 0.15 per cent of the voting rights (124,406 shares), in each case in accordance with Section 22 Sub-Section 1 No. 1 of the Federal Securities Trading Act, and c) Impala Fund Ltd. (a Cayman Islands exempted company) for 1.50 per cent of the voting rights (1,210,633 shares) in accordance with Section 22 Sub-Section 2 of the Federal Securities Trading Act. Furthermore Nordhues & Cie. LLP, with its registered office in Frankfurt/Main, Germany, notified us in the name and on behalf of Impala Asset Management, LLC, New Canaan, USA, on 07 May 2008, of the following: On 22 April 2008, the voting rights in Q-Cells AG exercised by Impala Asset Management, LLC., have fallen below the threshold of 3 % of the voting rights in Q-Cells AG and as of that day reached 2.97 % of the voting rights in Q-Cells AG, arising from 2,396,188 voting rights. The voting rights were to be allocated to a) Impala Fund Ltd. (a Cayman Islands exempted company) for 1.50 per cent of the voting rights (1,210,633 shares); b) Impala Fund LP (a Delaware limited partnership) for 1.03 per cent of the voting rights (831,367 shares); and c) Impala Alternative Energy Fund Ltd. for 0.28 per cent of the voting rights (229,782 shares); and d) Impala Alternative Energy Fund LP for 0.15 per cent of the voting rights (124,406 shares), in each case in accordance with Section 22 Sub-Section 1 No. 6 of the Federal Securities Trading Act. Furthermore Nordhues & Cie. LLP, with its registered office in Frankfurt/Main, Germany, notified us in the name and on behalf of Impala Fund Ltd., Grand Cayman, Cayman Islands, 07 May 2008, of the following: On 22 April 2008, the voting rights in Q-Cells AG of Impala Fund Ltd. (a Cayman Islands exempted company) have fallen below the threshold of 3 % of the voting rights in Q-Cells AG and as of that day reached 2.53 % of the voting rights in Q-Cells AG, representing 2,042,000 voting rights. 1.03 per cent of the above mentioned voting rights (or 831,367 shares) were to be allocated to Impala Fund Ltd. in accordance with Section 22 Sub-Section 2 of the Federal Securities Trading Act which arose out of shares held by Impala Fund LP. (a Cayman Islands exempted company). Both funds are managed by Impala Asset Management LLC, run the same strategy and vote in concert. Furthermore Nordhues & Cie. LLP, with its registered office in Frankfurt/Main, Germany, notified us in the name and on behalf of Impala Fund LP, New Canaan, USA, on 07 May 2008, of the following: On 22 April 2008, the voting rights in Q-Cells AG of Impala Fund LP (a Delaware limited partnership), have fallen below the threshold of 3 % of the voting rights in Q-Cells AG and as of that day reached 2.53 % of the voting rights in Q-Cells AG, representing 2,042,000 voting rights. 1.50 per cent of the above mentioned voting rights (or 1,210,633 shares) were to be allocated to Impala Fund LP in accordance with Section 22 Sub-Section 2 of the Federal Securities Trading Act which arose out of shares held by Impala Fund Ltd. (a Cayman Islands exempted company). Both funds are managed by Impala Asset Management LLC, run the same strategy and vote in concert. Bitterfeld-Wolfen, 13 May 2008 Q-Cells AG, OT Thalheim, Guardianstr. 16, 06766 Bitterfeld-Wolfen --- End of Message --- Q-Cells AG OT Thalheim, Guardianstr. 16 Bitterfeld-Wolfen Germany WKN: 555866; ISIN: DE0005558662; Index: CDAX, GEX, Prime All Share, TecDAX; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Börse Stuttgart;